Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

Galectin Therapeutics, Inc. (GALT)

-NCM
5.70 Down 8.84(60.80%) 4:00PM EDT
|After Hours : 5.79 Up 0.09 (1.58%) 4:24PM EDT - Nasdaq Real Time Price
Prev Close:14.54
Open:7.10
Bid:5.68 x 900
Ask:5.76 x 100
1y Target Est:29.50
Beta:0.88
Next Earnings Date:N/A
Day's Range:5.15 - 7.75
52wk Range:4.93 - 19.11
Volume:7,578,396
Avg Vol (3m):298,559
Market Cap:124.88M
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALT

Comparison

Symbol% ChgMkt Cap
GALTDown 60.80%124.88M
MNTAUp 2.91%563.89M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.94
Quarterly EPS Est (Jun-14) :-0.21
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galectin Therapeutics Inc., a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidates include GR-MD-02, a complex polysaccharide polymer for the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback